The stock is already up 65% the last two weeks, so obviously it’s getting play. I am long from $10 and again today at $11.34 and only mention it now because the volume hasn’t exploded yet and I do think it goes higher in this craze.
This was published in 2005.
Another study
Inhalation of nitric oxide (NO) improved arterial oxygenation and enabled the reduction of inspired oxygen therapy and airway pressure support in patients with severe acute respiratory syndrome (SARS). In addition, chest radiography showed decreased spread or density of lung infiltrates, and the physiological effects remained after termination of inhaled NO therapy. These findings suggest not only a pulmonary vasodilator effect of inhaled NO, but also an effect on SARS.
What does Beyond Air do?
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) delivery systems to treat respiratory tract infections and other diseases. Its NO delivery systems are used for the treatment of pulmonary hypertension of the newborn, bronchiolitis, and nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. The company is based in Garden City, New York
Tomorrow is their first ever analyst day. The agenda.
- Beyond Air’s first-ever analyst day, to be held March 5, will highlight the value of its LungFit nitric oxide (NO) platform and the potential of its clinical pipeline.
- LungFit PH (pulmonary hypertension) Pre Market Approval (PMA) submission is expected to be completed around the end of April and is on track for a 4Q20 launch.
- LungFit BRO (bronchiolitis) pilot study enrollment is expected to be completed by the end of February with data reported around midyear.
- LungFit NTM (non-tuberculous mycobacteria) proof of concept (POC) study will be initiated to evaluate its at-home program around midyear.
- Coronavirus (COVID-19) highlights the need for novel therapies for the treatment of bacterial and viral lung infections.
Perhaps it flops and I send up chalking up a virus bowser. But maybe it doesn’t. Either way, this narrative makes for interesting trades.
LONG NITRIC OXIDE.
If you enjoy the content at iBankCoin, please follow us on Twitter
I wonder if nitrous oxide (laughing gas) works too? Off to do some whip-its!
Old skool NO2! Used to take that prior to workouts and you’d feel so damn swole.
A couple scoops of NOXplode, that’ll get you jacked up to hit the gym without fear of the flu.
Regarding your post of earlier today – I wouldn’t go so far as to say that a president doesn’t matter to markets at all. But yeah, Bernie would not be allowed to do 95% of what he wants as far as handouts and such.
But where a president does matter is in foreign policy – and powerful interests will seek to keep anyone who they think has firm principals out of that office. Gabbard and Sanders need not apply.